RSS-Feed abonnieren
DOI: 10.1055/s-0038-1656008
Thrombin Augments Vascular Cell-dependent Migration of Human Mast Cells: Role of MGF
Publikationsverlauf
Received 16. Juli 1996
Accepted after revision 05. November 1996
Publikationsdatum:
26. Juli 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/199703/lookinside/thumbnails/10-1055-s-0038-1656008-1.jpg)
Summary
Recent data suggest that auricular thrombosis is associated with accumulation of mast cells (MC) in the upper endocardium (where usually no MC reside) and local expression of MGF (mast cell growth factor) (25). In this study, the role of vascular cells, thrombin-activation and MGF, in MC-migration was analyzed. For this purpose, cultured human auricular endocardial cells (HAUEC), umbilical vein endothelial cells (HUVEC) and uterine-(HUTMEC) and skin-derived (HSMEC) microvascular endothelial cells were exposed to thrombin or control medium, and the migration of primary tissue MC (lung, n = 6) and HMC-1 cells (human MC-line) against vascular cells (supernatants) measured. Supernatants (24 h) of unstimulated vascular cells (monolayers of endocardium or endothelium) as well as recombinant (rh) MGF induced a significant migratory response in HMC-1 (control: 3025 ± 344 cells [100 ± 11.4%] vs. MGF, 100 ng/ml: 8806 ± 1019 [291 ± 34%] vs. HAUEC: 9703 ± 1506 [320.8 ± 49.8%] vs. HUTMEC: 8950 ± 1857 [295.9 ± 61.4%] vs. HSMEC: 9965 ± 2018 [329.4 ± 66.7%] vs. HUVEC: 9487 ± 1402 [313.6 ± 46.4%], p <0.05) as well as in primary lung MC. Thrombin-activation (5 U/ml, 12 h) of vascular cells led to an augmentation of the directed migration of MC as well as to a hirudin-sensitive increase in MGF synthesis and release. Moreover, a blocking anti-MGF antibody was found to inhibit MC-migration induced by unstimulated or thrombin-activated vascular cells. Together, these data show that endocardial and other vascular cells can induce migration of human MC. This MC-chemotactic signal of the vasculature is associated with expression and release of MGF, augmentable by thrombin, and may play a role in the pathophysiology of (auricular) thrombosis.
-
References
- 1 Galli SJ. Biology of disease:New insights into “the riddle of the mast cells”:microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 1990; 62: 0005-0033
- 2 Ishizaka T, Ishizaka K. Activation of mast cells for mediator release through IgE receptors. Prog Allergy 1984; 34: 0188-0235
- 3 Serafin WE, Austen KF. Mediators of immediate hypersensitivity reactions. New Engl J Med 1987; 317: 0030-0034
- 4 Siraganian RP. Biochemical events in basophil/mast cell activation and mediator secretion. In: Allergy. Kaplan AP. ed. Edinburgh; Churchill Livingstone: 1985. 01. pp 0031-0051
- 5 Kitamura Y, Yokoyama M, Matsuda H, Ohno T, Mori KJ. Spleen colony forming cell as common precursor for tissue mast cells and granulocytes. Nature 1981; 291: 0159-0160
- 6 Agis H, Willheim M, Sperr WR, Wilfing A, Krӧmer E, Kabrna E, Spanblӧchl E, Strobl H, Geissler K, Spittler A, Boltz-Nitulescu G, Majdic O, Lechner K, Valent P. Monocytes do not make mast cells when cultured in the presence of SCF:Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony forming cell. J Immunol 1993; 151: 4221-4227
- 7 Fӧdinger M, Fritsch G, Winkler K, Emminger W, Mitterbauer G, Gadner H, Valent P, Mannhalter C. Origin of human mast cells:Development from transplanted hemopoietic stem cells after allogeneic bone marrow transplantation. Blood 1994; 84: 2954-2959
- 8 Valent P. The riddle of the mast cell:kit (CD117)-ligand as the missing link?. Immunol Today 1994; 15: 0111-0114
- 9 Kirshenbaum AS, Kessler SW, Goff JP, Metcalfe DD. Demonstration of the origin of human mast cells from CD34+bone marrow progenitor cells. J Immonol 1991; 146: 1410-1415
- 10 Valent P, Spanblochl E, Sperr WR, Sillaber C, Agis H, Strobl H, Zsebo KM, Geissler K, Bettelheim P, Lechner K. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor (SCF)/kit ligand (KL) in long term culture. Blood 1992; 80: 2237-2245
- 11 Rottem M, Okada T, Goff JP, Metcalfe DD. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/FcRI-cell population. Blood 1994; 84: 2489-2496
- 12 Kirshenbaum AS, Goff JP, Kessler SW, Mican JM, Zsebo KM, Metcalfe DD. Effects of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+pluripotent progenitor cells. J Immunol 1992; 148: 0772-0777
- 13 Mitsui H, Furitsu T, Dvorak AM, Irani A-M, Schwartz LB, Inagaki N, Takei M, Ishizaka K, Zsebo KM, Gillis S. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci (USA) 1990; 90: 0735-0740
- 14 Bischoff SC, Dahinden CA. c-kit ligand:A unique potentiator of mediator release by human lung mast cells. J Exp Med 1992; 175: 0237-0244
- 15 Columbo M, Horowitz EM, Botana LM, MacGlashan DWJ, Bochner BS, Gillis S, Zsebo KM, Galli SJ, Lichtenstein LM. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 1992; 149: 0599-0608
- 16 Sperr WR, Czerwenka K, Mundigler G, Muller MR, Semper H, Klappacher G, Glogar D, Lechner K, Valent P. Specific activation of human mast cells by the ligand for c-kit:comparison between lung-, uterus and heart mast cells. Int Arch Allergy Appl Immunol 1993; 102: 0170-0175
- 17 Nilsson G, Butterfield JH, Nilsson K, Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 1994; 153: 3717-3723
- 18 Meininger CJ, Yano H, Rottapel R, Bernstein A, Zsebo KM, Zetter BR. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 1992; 79: 0958-0963
- 19 Linenberger ML, Jacobson FW, Bennett LG, Broudy VC, Martin FH, Abkowitz JL. Stem cell factor production by human marrow stromal fibroblasts. Exp Hematol 1995; 23: 1104-1114
- 20 Heinrich MC, Dooley DC, Freed AC, Band L, Hoatlin ME, Keeble WW, Peters ST, Silvey KV, EY FS, Kabat D, Maziarz RT, Bagby jr GC. Constitutive expression of steel factor gene by human stroma cells. Blood 1993; 82: 0771-0783
- 21 Aye MT, Hashemi S, Leclair B, Zaibdawi A, Trudel E, Halpenny M, Fuller V, Cheng G. Expression of stem cell factor and c-kit mRNA in cultured endothelial cells, monocytes and cloned human bone marrow stromal cells (CFU-RF). Exp Hematol 1992; 20: 0523-0527
- 22 Koenig A, Yakisan E, Reuter M, Huang M, Sykora KW, Corbacioglu S, Welte K. Differential regulation of stem cell factor mRNA expression in human endothelial cells by bacterial pathogens:An in vitro model of inflammation. Blood 1994; 83: 2836-2843
- 23 Anderson DM, Lyman SD, Baird A, Wignal JM, Eisenmann J, Rauch C, March CJ, Boswell HS, Gimpel SD, Cosman D. et al. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 1990; 63: 0235-0244
- 24 Flanagan JG, Chan DC, Leder P. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the S1dmutant. Cell 1991; 64: 1025-1035
- 25 Bankl HC, Radaszkiewicz Th, Klappacher GW, Glogar D, Sperr WR, Großschmidt K, Bankl H, Lechner K, Valent P. Increase and redistribution of mast cells in auricular thrombosis:possible role of kit ligand. Circulation 1995; 91: 0275-0283
- 26 Schulman ES, Mac GlashanDW, Peters SP, Schleimer RP, Newball HH, Lichtenstein LM. Lung mast cells:purification and characterization. J Immunol 1982; 129: 2662-2667
- 27 Butterfield JH, Weiler D, Dewald G, Gleich GJ. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 1988; 12: 0345-0355
- 28 Kapiotis S, Besemer J, Bevec D, Valent P, Bettelheim P, Lechner K, Speiser W. Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells. Blood 1991; 77: 0410-0415
- 29 Wojta J, Zoellner H, Galliccio M, Hamilton JA, McGrath K. γ-Interferon counteracts interleukin-lαstimulated expression of urokinase-type plasminogen activator in human endothelial cells in vitro. Biochem Bioph Res Co 1992; 188: 0463-0469
- 30 Maciag T, Hoover GA, Stemerman MB, Wellnstein R. Factors which stimulate the growth of human umbilical vein endothelial cells in culture. In: biology of endothelial cells. Jaffe EA. ed. Dortrecht: Martinus Nijhoff Pub; 1984. pp 0087-0096
- 31 Baghestanian M, Agis H, Bevec D, Bankl HC, Hofbauer R, Kress HG, Butterfield JH, Muller MR, Ashman LK, Füreder W, Willheim M, Lechner K, Valent P. Stem cell factor induced downregulation of c-kit in human lung mast cells and HMC-1 mast cells. Exp Hematol 1996; 24: 1377-1386
- 32 Valent P, Ashman LK, Hinterberger W, Eckersberger F, Majdic O, Lechner K, Bettelheim P. Mast cell typing:demonstration of a distinct hemopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. Blood 1989; 73: 1778-1785
- 33 Valent P, Bevec D, Maurer D, Besemer J, Di PadovaF, Butterfield JH, Speiser W, Majdic O, Lechner K, Bettelheim P. Interleukin 4 promotes expression of mast cell ICAM-1 antigen. Proc Natl Acad Sci USA 1991; 88: 3339-3342
- 34 Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active RNA from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294-5299
- 35 Martin FH, Suggs SV, Langley KE, Lu HS, Ting J, Okino KH, Morris CF, McNiece LK, Jacobsen FW, Mendiaz EA, Birkett NC, Smith KA, Johnson MJ, Parker VP, Flores JC, Patel AC, Fisher EF, Erjavec HO, Herrera CJ, Wypych J, Sachdev RK, Pope JA, Leslie I, Wen D, Lin C-H, Cupples RL, Szebo KM. Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 1990; 63: 0203-0211
- 36 Ponte P, Ng S-Y, Engel J, Gunning P, Kedes L. Evolutionary conservation in the untranslated regions of actin mRNAs:DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 1984; 12: 1687-1696
- 37 Kitamura Y, Go S. Decreased production of mast cells in Sl/Sldmice. Blood 1979; 53: 0492-0497
- 38 Dvorak AM. Human mast cells. Adv Anat Cell Biol 1989; 114: 0001-0107
- 39 Meininger CJ, Brightman SE, Kelly KA, Zetter BR. Increased stem cell factor release by hemangioma-derived endothelial cells. Lab Invest 1995; 72: 0166-0173
- 40 Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor, which induces endothelial leucocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991; 88: 4220-4224
- 41 Klein LM, Lavker RM, Matis WL, Murphy GF. Degranulation of human mast cells induces an endothelial cell antigen central to leucocyte adhesion. Proc Natl Acad Sci USA 1989; 86: 8972-8976
- 42 Baghestanian M, Sillaber C, Bevec D, Füreder W, Agis H, Muller MR, Willheim M, Raidl M, Kapiotis M, Speiser W, Bettelheim P, Lechner K, Valent P. Expression of pro-fibrinolytic activity, a high tPA/PAI ratio and uPAR/CD87 in human mast cells. Blood 1994; 84 (Suppl. 01) 0076a (Abstract)